Literature DB >> 11108286

Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.

M Takami1, N Takahashi, N Udagawa, C Miyaura, K Suda, J T Woo, T J Martin, K Nagai, T Suda.   

Abstract

Receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) produced by osteoblasts/stromal cells are involved as positive and negative regulators in osteoclast formation. Three independent signals have been proposed to induce RANKL expression in osteoblasts/stromal cells: vitamin D receptor-, cAMP-, and gp130-mediated signals. We previously reported that intracellular calcium-elevating compounds such as ionomycin, cyclopiazonic acid, and thapsigargin induced osteoclast formation in cocultures of mouse bone marrow cells and primary osteoblasts. Increases in calcium concentration in culture medium also induced osteoclast formation in cocultures. Treatment of primary osteoblasts with these compounds or with high calcium medium stimulated the expression of both RANKL and OPG messenger RNAs (mRNAs). 1,2-Bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid)-tetra(acetoxymethyl)ester, an intracellular calcium chelator, suppressed both ionomycin-induced osteoclast formation in cocultures and expression of RANKL and OPG mRNAs in primary osteoblasts. Phorbol 12-myristate 13-acetate (PMA), an activator of protein kinase C, also stimulated osteoclast formation in these cocultures and the expression of RANKL and OPG mRNAs in primary osteoblasts. Protein kinase C inhibitors such as calphostin and staurosporin suppressed ionomycin- and PMA-induced osteoclast formation in cocultures and expression of RANKL and OPG mRNAs in primary osteoblasts. Ionomycin stimulated RANKL mRNA expression in ST2 and MC3T3-G2/PA6 cells, but not in MC3T3-E1 or NIH-3T3 cells. These effects were closely correlated with osteoclast formation in response to ionomycin in cocultures with these stromal cell lines. OPG strongly inhibited osteoclast formation induced by calcium-elevating compounds and PMA in cocultures, suggesting that RANKL expression in osteoblasts is a rate-limiting step for osteoclast induction. Forskolin, an activator of cAMP signals, also stimulated osteoclast formation in cocultures. Forskolin enhanced RANKL mRNA expression but suppressed OPG mRNA expression in primary osteoblasts. These results suggest that the calcium/protein kinase C signal in osteoblasts/stromal cells is the fourth signal for inducing RANKL mRNA expression, which, in turn, stimulates osteoclast formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108286     DOI: 10.1210/endo.141.12.7852

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Bone Morphogenetic Protein-2 (BMP-2) Activates NFATc1 Transcription Factor via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling.

Authors:  Chandi C Mandal; Falguni Das; Suthakar Ganapathy; Stephen E Harris; Goutam Ghosh Choudhury; Nandini Ghosh-Choudhury
Journal:  J Biol Chem       Date:  2015-10-15       Impact factor: 5.157

2.  Osteoprotegerin levels in patients with severe mental disorders.

Authors:  Sigrun Hope; Ingrid Melle; Pål Aukrust; Ingrid Agartz; Steinar Lorentzen; Nils Eiel Steen; Srdjan Djurovic; Thor Ueland; Ole A Andreassen
Journal:  J Psychiatry Neurosci       Date:  2010-09       Impact factor: 6.186

3.  Internal prostaglandin synthesis augments osteoprotegerin production in human gingival fibroblasts stimulated by lipopolysaccharide.

Authors:  M Kiji; T Nagasawa; D Hormdee; R Yashiro; H Kobayashi; K Noguchi; H Nitta; Y Izumi; I Ishikawa
Journal:  Clin Exp Immunol       Date:  2007-06-05       Impact factor: 4.330

4.  Effects of soluble silicon compound and deep-sea water on biochemical and mechanical properties of bone and the related gene expression in mice.

Authors:  Fusako Maehira; Yoshirou Iinuma; Yukinori Eguchi; Ikuko Miyagi; Shoei Teruya
Journal:  J Bone Miner Metab       Date:  2008-08-30       Impact factor: 2.626

5.  Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways.

Authors:  Masanobu Tsubaki; Chisato Kato; Miyuki Manno; Mitsuhiko Ogaki; Takao Satou; Tatsuki Itoh; Takashi Kusunoki; Yoshihiro Tanimori; Kimiko Fujiwara; Hiroshi Matsuoka; Shozo Nishida
Journal:  Mol Cell Biochem       Date:  2007-06-05       Impact factor: 3.396

6.  RANKL is a downstream mediator for insulin-induced osteoblastic differentiation of vascular smooth muscle cells.

Authors:  Ling-Qing Yuan; Jia-Hua Zhu; Hua-Wen Wang; Qiu-Hua Liang; Hui Xie; Xian-Ping Wu; Hua Zhou; Rong-Rong Cui; Zhi-Feng Sheng; Hou-De Zhou; Xiao Zhu; Guan-Ying Liu; You-Shuo Liu; Er-Yuan Liao
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

7.  Mitochondrial superoxide in osteocytes perturbs canalicular networks in the setting of age-related osteoporosis.

Authors:  Keiji Kobayashi; Hidetoshi Nojiri; Yoshitomo Saita; Daichi Morikawa; Yusuke Ozawa; Kenji Watanabe; Masato Koike; Yoshinori Asou; Takuji Shirasawa; Koutaro Yokote; Kazuo Kaneko; Takahiko Shimizu
Journal:  Sci Rep       Date:  2015-03-16       Impact factor: 4.379

8.  Cell adhesion signaling regulates RANK expression in osteoclast precursors.

Authors:  Ayako Mochizuki; Masamichi Takami; Yoichi Miyamoto; Tsuyoshi Nakamaki; Shigeru Tomoyasu; Yuho Kadono; Sakae Tanaka; Tomio Inoue; Ryutaro Kamijo
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

9.  MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha.

Authors:  Nobuaki Sato; Naoyuki Takahashi; Koji Suda; Midori Nakamura; Mariko Yamaki; Tadashi Ninomiya; Yasuhiro Kobayashi; Haruhiko Takada; Kenichiro Shibata; Masahiro Yamamoto; Kiyoshi Takeda; Shizuo Akira; Toshihide Noguchi; Nobuyuki Udagawa
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

10.  Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKL.

Authors:  N C Walsh; K A Alexander; C A Manning; S Karmakar; S K Karmakar; J F Wang; C M Weyand; A R Pettit; E M Gravallese
Journal:  Genes Immun       Date:  2013-05-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.